Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of a new prostaglandin E1 regimen in outpatients with severe intermittent claudication: results of a multicenter placebo-controlled double-blind trial.
Diehm C, Balzer K, Bisler H, Bulling B, Camci M, Creutzig A, Gruss JD, Horsch S, Odemar F, Piehler U, Rogatti W, Scheffler P, Spengel F, Treese N, Turowski A, Waldhausen P, Weber B, Weiss T. Diehm C, et al. Among authors: spengel f. J Vasc Surg. 1997 Mar;25(3):537-44. doi: 10.1016/s0741-5214(97)70265-9. J Vasc Surg. 1997. PMID: 9081136 Free article. Clinical Trial.
The efficacy and safety of a coumarin-/troxerutin-combination (SB-LOT) in patients with chronic venous insufficiency: a double blind placebo-controlled randomised study.
Vanscheidt W, Rabe E, Naser-Hijazi B, Ramelet AA, Partsch H, Diehm C, Schultz-Ehrenburg U, Spengel F, Wirsching M, Götz V, Schnitker J, Henneicke-von Zepelin HH. Vanscheidt W, et al. Among authors: spengel f. Vasa. 2002 Aug;31(3):185-90. doi: 10.1024/0301-1526.31.3.185. Vasa. 2002. PMID: 12236023 Clinical Trial.
Low-dose iloprost infusions compared to the standard dose in patients with peripheral arterial occlusive disease Fontaine stage IV. DAWID Study Group.
Beischer W, Dembski JC, Gruss JD, Hofgärtner F, Horsch A, Horsch S, Kuhlmann HW, Loose DA, Mietaschk A, Schwilden ED, Spengel F, Spitzer W, Staben P, Stallkamp B, Stürzebecher CS, Tokhi M, von Bilderling P. Beischer W, et al. Among authors: spengel f. Vasa. 1998 Feb;27(1):15-9. Vasa. 1998. PMID: 9540427 Clinical Trial.
Die medikamentöse Therapie der arteriellen Verschlusskrankheit.
Diehm C, Heidrich H, Spengel F, Schulte KL, Theiss W. Diehm C, et al. Among authors: spengel f. Internist (Berl). 2000 Nov;41(12):1416-1422. doi: 10.1007/s001080050709. Internist (Berl). 2000. PMID: 28550333 German. No abstract available.
[Drug therapy of arterial occlusive disease].
Diehm C, Heidrich H, Spengel F, Schulte KL, Theiss W. Diehm C, et al. Among authors: spengel f. Internist (Berl). 2000 Dec;41(12):1416-22. Internist (Berl). 2000. PMID: 11189078 Review. German. No abstract available.
[Angiolog].
Spengel FA, Creutzig A. Spengel FA, et al. Internist (Berl). 1998 Apr;39(4):340-1. doi: 10.1007/s001080050178. Internist (Berl). 1998. PMID: 9599742 Review. German. No abstract available.
85 results